• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

显著的组织特异性突变长度增加是亨廷顿舞蹈病发病机制中的一个早期分子事件。

Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.

作者信息

Kennedy Laura, Evans Elizabeth, Chen Chiung-Mei, Craven Lyndsey, Detloff Peter J, Ennis Margaret, Shelbourne Peggy F

机构信息

Division of Molecular Genetics, Faculty of Biomedical and Life Scienes, University of Glasgow, Anderson College Complex, 56 Dumbarton Road, Glasgow G11 6NU, UK.

出版信息

Hum Mol Genet. 2003 Dec 15;12(24):3359-67. doi: 10.1093/hmg/ddg352. Epub 2003 Oct 21.

DOI:10.1093/hmg/ddg352
PMID:14570710
Abstract

Huntington disease is caused by the expansion of a CAG repeat encoding an extended glutamine tract in a protein called huntingtin. Although the mutant protein is widely expressed, the earliest and most striking neuropathological changes are observed in the striatum. Here we show dramatic mutation length increases (gains of up to 1000 CAG repeats) in human striatal cells early in the disease course, most likely before the onset of pathological cell loss. Studies of knock-in HD mouse models indicate that the size of the initial CAG repeat mutation may influence both onset and tissue-specific patterns of age-dependent, expansion-biased mutation length variability. Given that CAG repeat length strongly correlates with clinical severity, we suggest that somatic increases of mutation length may play a major role in the progressive nature and cell-selective aspects of both adult-onset and juvenile-onset HD pathogenesis and we discuss the implications of this interpretation of the data presented.

摘要

亨廷顿舞蹈症是由一个CAG重复序列的扩增引起的,该重复序列编码一种名为亨廷顿蛋白的蛋白质中的一段延长的谷氨酰胺序列。尽管突变蛋白广泛表达,但最早且最显著的神经病理学变化出现在纹状体中。在这里,我们展示了在疾病进程早期,人类纹状体细胞中显著的突变长度增加(增加多达1000个CAG重复序列),很可能发生在病理性细胞丢失开始之前。对敲入型亨廷顿舞蹈症小鼠模型的研究表明,初始CAG重复突变的大小可能会影响年龄依赖性、扩增偏向性突变长度变异性的发病年龄和组织特异性模式。鉴于CAG重复长度与临床严重程度密切相关,我们认为突变长度的体细胞增加可能在成人发病型和青少年发病型亨廷顿舞蹈症发病机制的进行性本质和细胞选择性方面起主要作用,并且我们讨论了这种对所呈现数据的解释的含义。

相似文献

1
Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.显著的组织特异性突变长度增加是亨廷顿舞蹈病发病机制中的一个早期分子事件。
Hum Mol Genet. 2003 Dec 15;12(24):3359-67. doi: 10.1093/hmg/ddg352. Epub 2003 Oct 21.
2
Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain.三联体重复突变长度增加与亨廷顿病大脑中细胞类型特异性易损性相关。
Hum Mol Genet. 2007 May 15;16(10):1133-42. doi: 10.1093/hmg/ddm054. Epub 2007 Apr 4.
3
Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse.亨廷顿病基因敲入小鼠中长度依赖性配子CAG重复序列不稳定性
Hum Mol Genet. 1999 Jan;8(1):115-22. doi: 10.1093/hmg/8.1.115.
4
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.表达突变全长亨廷顿舞蹈病(HD)互补DNA的转基因小鼠:亨廷顿舞蹈病运动变化和选择性神经元丢失的范例
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456.
5
Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice.R6/2亨廷顿病小鼠等位基因系列中年龄、组织和长度依赖性双向体细胞CAG•CTG重复序列不稳定性
Neurobiol Dis. 2015 Apr;76:98-111. doi: 10.1016/j.nbd.2015.01.004. Epub 2015 Feb 3.
6
Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.不间断的 CAG 重复驱动人类亨廷顿 BAC 小鼠纹状体选择性转录病和核发病。
Neuron. 2022 Apr 6;110(7):1173-1192.e7. doi: 10.1016/j.neuron.2022.01.006. Epub 2022 Feb 2.
7
Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.亨廷顿舞蹈病转基因小鼠模型中对丙二酸酯诱导的纹状体细胞死亡的部分抗性取决于年龄和CAG重复长度。
J Neurochem. 2001 Aug;78(4):694-703. doi: 10.1046/j.1471-4159.2001.00482.x.
8
Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.Msh2 在中型棘状纹状体神经元中作为亨廷顿病基因敲入小鼠中 CAG 不稳定性和突变 huntingtin 表型的增强子发挥作用。
PLoS One. 2012;7(9):e44273. doi: 10.1371/journal.pone.0044273. Epub 2012 Sep 7.
9
HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation.HdhQ111小鼠表现出组织特异性代谢物谱,包括纹状体脂质积累。
PLoS One. 2015 Aug 21;10(8):e0134465. doi: 10.1371/journal.pone.0134465. eCollection 2015.
10
Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.R6/2小鼠中由超长CAG重复序列扩增导致的疾病发病出现反常延迟。
Neurobiol Dis. 2009 Mar;33(3):331-41. doi: 10.1016/j.nbd.2008.11.015. Epub 2008 Dec 11.

引用本文的文献

1
Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion.亨廷顿舞蹈症连接酶1修饰变体可提高连接酶保真度并抑制体细胞中CAG重复序列的扩增。
bioRxiv. 2025 Jul 18:2025.07.15.664798. doi: 10.1101/2025.07.15.664798.
2
Blocking somatic repeat expansion and lowering huntingtin via RNA interference synergize to prevent Huntington's disease pathogenesis in mice.通过RNA干扰阻断体细胞重复序列扩增并降低亨廷顿蛋白,二者协同作用可预防小鼠亨廷顿病的发病机制。
bioRxiv. 2025 Jun 25:2025.06.24.661398. doi: 10.1101/2025.06.24.661398.
3
Direct Observation of Secondary Nucleation in Huntingtin Amyloid Formation by High-Speed Atomic Force Microscopy.
通过高速原子力显微镜直接观察亨廷顿蛋白淀粉样蛋白形成过程中的二次成核
J Am Chem Soc. 2025 Jun 25;147(25):21973-21984. doi: 10.1021/jacs.5c05571. Epub 2025 Jun 12.
4
Epigenetic mechanisms governing cell type specific somatic expansion and toxicity in Huntington's disease.调控亨廷顿舞蹈病中细胞类型特异性体细胞扩增和毒性的表观遗传机制。
bioRxiv. 2025 May 26:2025.05.21.653721. doi: 10.1101/2025.05.21.653721.
5
Double strand breaks drive toxicity in Huntington's disease mice with or without somatic expansion.双链断裂在有或没有体细胞扩增的亨廷顿舞蹈症小鼠中引发毒性。
bioRxiv. 2025 May 28:2025.05.27.654663. doi: 10.1101/2025.05.27.654663.
6
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease highlight shared and tissue-specific effects.亨廷顿舞蹈病中体细胞扩增和临床表型的遗传修饰因子凸显了共同效应和组织特异性效应。
Nat Genet. 2025 Jun;57(6):1426-1436. doi: 10.1038/s41588-025-02191-5. Epub 2025 Jun 9.
7
CoREST in pieces: Dismantling the CoREST complex for cancer therapy and beyond.CoREST分解:为癌症治疗及其他领域拆解CoREST复合物
Sci Adv. 2025 Jun 6;11(23):eads6556. doi: 10.1126/sciadv.ads6556.
8
Interventionally targeting somatic CAG expansions can be a rapid disease-modifying therapeutic avenue: Preclinical evidence.通过干预靶向体细胞CAG重复扩增可能是一条快速改善疾病的治疗途径:临床前证据。
bioRxiv. 2025 Apr 28:2025.04.25.650652. doi: 10.1101/2025.04.25.650652.
9
CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse models.在双等位基因人源化多聚谷氨酰胺小鼠模型中测试的针对CAG的脑渗透性疗法。
Mol Ther Nucleic Acids. 2025 Feb 22;36(2):102496. doi: 10.1016/j.omtn.2025.102496. eCollection 2025 Jun 10.
10
Errors in the Huntington's disease gene accumulate slowly and then all at once.亨廷顿舞蹈症基因中的错误缓慢累积,然后突然全面爆发。
Nature. 2025 Mar;639(8055):584-586. doi: 10.1038/d41586-025-00717-9.